Hospira Recalls Vancomycin Hydrochloride Injection Due to Temperature Excursions
Hospira Inc. is recalling 90,600 vials of Vancomycin Hydrochloride for Injection because the products experienced uncontrolled temperature excursions during transit.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves temperature excursions which may affect drug stability, but no specific injuries or illnesses are reported in the source text.
Plain-English summary
Hospira Inc. is recalling 90,600 vials of Vancomycin Hydrochloride for Injection, USP, 1 g Sterile Powder per Fliptop Vial. The recall is due to uncontrolled temperature excursions that occurred during transit. The affected product is identified by Lot # 35-315-DD and has an expiration date of 1NOV2015.
The distribution of the affected Vancomycin 1 g product was nationwide. Other lots of Vancomycin 500 mg, Ketorolac tromethamine, and Propofol were limited to a single shipment to The Harvard Drug Group in Livonia, MI, and remained within the distributor's control without further distribution.
Healthcare providers and patients should stop using the affected product and contact Hospira Inc. for further instructions. Consumers should not use the recalled medication and should return it to their pharmacy or healthcare provider.
The recalled product
- Product
- VANCOMYCIN HYDROCHLORIDE (VANCOMYCIN HYDROCHLORIDE)
- Brand
- VANCOMYCIN HYDROCHLORIDE
- Manufacturer
- Hospira Inc.
- Category
- Drug — Antibiotic Injection
- Affected units
- 90,600
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 35-315-DD
- Exp 1NOV2015
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by Hospira Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same brand · VANCOMYCIN HYDROCHLORIDE
- SevereVancomycin Hydrochloride Oral Solution Recalled Nationwide for Superpotency Due to Overfilling
FDA (Drugs) · 2024-04-24
- CriticalVancomycin Hydrochloride Injection Recalled for Glass Particulate Matter
FDA (Drugs) · 2023-02-01
- ModerateAuroMedics Recalls Vancomycin Hydrochloride Vials Due to Discoloration
FDA (Drugs) · 2019-12-18
- CriticalPfizer Recalls Vancomycin Hydrochloride Vials Due to Glass Particulate Matter
FDA (Drugs) · 2017-12-27
- ModerateHospira Recalls Vancomycin Hydrochloride Injection Due to Temperature Abuse
FDA (Drugs) · 2015-02-25
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · temperature abuse
See all →- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- ModerateGarland Fresh peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- ModerateChristopher Ranch peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- SevereCrab Cakes Sold to Food Service Recalled for Botulism Risk
FDA (Food) · 2026-04-15
- CriticalUDENYCA syringes recalled after cartons were stored at room temperature
FDA (Drugs) · 2026-02-18